Precision-Engineered GPCR-Targeted Therapeutics
Orion’s platform and science unlocks the therapeutic potential of GPCR targets across a broad range of medical needs. Our approach allows us to focus our discovery and development efforts across peptide and protein GPCR subfamilies, generating a diversified pipeline of potential first-in-class/best-in-class antagonist and agonist therapies against high-value GPCR targets in oncology, immunology and other serious diseases.
-
Most popular related searches
Customer reviews
No reviews were found for Precision-Engineered GPCR-Targeted Therapeutics. Be the first to review!